Background: Renal osteodystrophy (ROD) is a bone disorder resulting from chronic kidney disease (CKD) and related metabolic diseases. Dickkopf-related protein-1 (DKK-1) is critical in regulating bone biology. This study aimed to evaluate the serum DKK-1 level as a bone marker in children with CKD who undergo regular hemodialysis (HD). Subjects and Methods: This case-control study involved 40 children with CKD on HD and 40 healthy children as controls. The study measured serum DKK-1 levels and performed a dual-energy X-ray absorptiometry scan (DEXA) in line with routine laboratory investigations. Results: There was a significant increase in the serum level of DKK-1 in the patient group compared to the control group. The DKK-1 levels were 2540.65 (2215.4 - 2909.2) pg/ml and 1110.45 (885.45 - 1527.65) pg/ml, respectively, with a p-value of less than 0.001. In the hemodialysis group, 25 patients (62.5%) had low bone mineral density (BMD) with a Z-score of under -2.0. Eighteen of these patients had low BMD in both the neck of the femur and lumbar spines. Additionally, there was a significant increase in serum DKK-1 level in patients with low BMD (2567.35 (2303.8 - 3108.1) pg/ml) compared to patients with normal BMD (2454 (1859 - 2820) pg/ml) (p = 0.041). There was also a significant positive correlation between DKK1 level and phosphorus, alkaline phosphatase, and Parathormone serum levels. In conclusion, the study indicates a clear correlation between DKK-1 and BMD in children undergoing maintenance hemodialysis. DKK1 is a promising biomarker for CKD-MBD.
References
[1]
Bisson, S.K., Ung, R.V. and Mac-Way, F. (2018) Role of the Wnt/β-Catenin Pathway in Renal Osteodystrophy. International Journal of Endocrinology, 2018, Article ID: 5893514. https://doi.org/10.1155/2018/5893514
[2]
Evenepoel,P., D’Haese,P. and Brandenburg,V. (2015) Sclerostin and DKK: New Players in Renal Bone and Vascular Disease. Kidney International, 88, 235-240. https://doi.org/10.1038/ki.2015.156
[3]
Forster, C.M., White, C.A., Turner, M.E., et al. (2020) Circulating Levels of Dickkopf-Related Protein 1 Decrease as Measured GFR Declines and Are Associated with PTH Levels. American Journal of Nephrology, 51, 871-880. https://doi.org/10.1159/000511658
[4]
Magalhães, J., Quelhas-Santos, J., Pereira, L., et al. (2022) Could Bone Biomarkers Predict Bone Turnover after Kidney Transplantation?—A Proof-of-Concept Study. Journal of Clinical Medicine, 11, Article 457. https://doi.org/10.3390/jcm11020457
[5]
Covic, A., Voroneanu, L. and Apetrii, M. (2016) PTH and/or Bone Histology: Are We Still Waiting for a Verdict from the CKD-MBD Grand Jury? American Journal of Kidney Diseases, 67, 535-538. https://doi.org/10.1053/j.ajkd.2015.11.028
[6]
Neto, R., Pereira, L., Magalhães, J., et al. (2021) Sclerostin and DKK1 Circulating Levels Associated with Low Bone Turnover in Patients with Chronic Kidney Disease Stages 3 and 4. Clinical Kidney Journal, 14, 2401-2408. https://doi.org/10.1093/ckj/sfab081
[7]
Shah, A. and Aeddula, N.R. (2023) Renal Osteodystrophy. StatPearls Publishing, Treasure Island.
[8]
Ikizler, T.A., et al. (2020) KDOQI Clinical Practice Guideline for Nutrition in CKD: 2020 Update. American Journal of Kidney Diseases, 76, S1-S107.
[9]
Lewiecki, E.M., Gordon, C.M., Baim, S., et al. (2008) Special Report on the 2007 Adult and Pediatric Position Development Conferences of the International Society for Clinical Densitometry. Osteoporosis International, 19, 1369-1378. https://doi.org/10.1007/s00198-008-0689-9
[10]
Slouma, M., Sahli, H., Bahlous, A., et al. (2020) Mineral Bone Disorder and Osteoporosis in Hemodialysis Patients. Advances in Rheumatology, 60, Article No. 15. https://doi.org/10.1186/s42358-020-0118-0
[11]
Pinzone, J.J., et al. (2009) The Role of Dickkopf-1 in Bone Development, Homeostasis, and Disease. Blood, 113, 517-525. https://doi.org/10.1182/blood-2008-03-145169
[12]
Ke, H.Z., Richards, W.G., Li, X. and Ominsky, M.S. (2012) Sclerostin and Dickkopf-1 as Therapeutic Targets in Bone Diseases. Endocrine Reviews, 33, 747-783. https://doi.org/10.1210/er.2011-1060
[13]
Suprapti, B., Hartono, F., Iqbal, M., et al. (2019) Paricalcitol for CKD-MBD Associated with Secondary Hyperparathyroidism: A Case Series Focus on TRAP5b, b-ALP, and DKK-1. Indonesian Journal of Pharmacy, 30, 66-73. https://doi.org/10.14499/indonesianjpharm30iss1pp66
[14]
Mazon, M., Larouche, V., St-Louis, M., et al. (2018) Elevated Blood Levels of Dickkopf-1 Are Associated with Acute Infections. Immunity, Inflammation, and Disease, 6, 428-434. https://doi.org/10.1002/iid3.232
[15]
Rossini, M., Viapiana, O., Adami, S., et al. (2015) In Patients with Rheumatoid Arthritis, Dickkopf-1 Serum Levels Are Correlated with Parathyroid Hormone, Bone Erosions and Bone Mineral Density. Clinical and Experimental Rheumatology, 33, 77-83.
[16]
Tjempakasari, A., Suroto, H. and Santoso, D. (2022) Osteoblastogenesis of Adipose-Derived Mesenchymal Stem Cells in Chronic Kidney Disease Patient with Regular Hemodialysis. Annals of Medicine and Surgery, 84, Article ID: 104796. https://doi.org/10.1016/j.amsu.2022.104796
[17]
Al-Hakeim, H.K., Asad, H.N. and Maes, M. (2021) Wnt/β-Catenin Pathway Proteins in End-Stage Renal Disease. Biomarkers in Medicine, 15, 1423-1434. https://doi.org/10.2217/bmm-2021-0177
[18]
Thambiah, S., Roplekar, R., Manghat, P., et al. (2012) Circulating Sclerostin and Dickkopf-1 (DKK1) in Predialysis Chronic Kidney Disease (CKD): Relationship with Bone Density and Arterial Stiffness. Calcified Tissue International, 90, 473-480. https://doi.org/10.1007/s00223-012-9595-4
[19]
Pickering, T.G., Hall, J.E., Appel, L.J., et al. (2005) Recommendations for Blood Pressure Measurement in Humans and Experimental Animals: Part 1: Blood Pressure Measurement in Humans: A Statement for Professionals from the Subcommittee of Professional and Public Education of the American Heart Association Council on High Blood Pressure Research. Circulation, 111, 697-716. https://doi.org/10.1161/01.CIR.0000154900.76284.F6
[20]
London, G.M. (2018) Arterial Stiffness in Chronic Kidney and End-Stage Renal Disease. Blood Purification, 45, 154-158. https://doi.org/10.1159/000485146
[21]
London, G.M., Safar, M.E. and Pannier, B. (2016) Aortic Ageing in ESRD: Structural, Hemodynamic, and Mortality Implications. Journal of the American Society of Nephrology, 27, 1837-1846. https://doi.org/10.1681/ASN.2015060617
[22]
Cannata-Andi, J.B., Rodri, M., Carrillo-Lo, N., et al. (2006) Vascular Calcifications: Pathogenesis, Management, and Impact on Clinical Outcomes. Journal of the American Society of Nephrology, 17, S267-S273. https://doi.org/10.1681/ASN.2006080925
[23]
Ali, H., Zmuda, J.M., Cvejkus, R.K., et al. (2019) Wnt Pathway Inhibitor DKK1: A Potential Novel Biomarker for Adiposity. Journal of the Endocrine Society, 3, 488-495. https://doi.org/10.1210/js.2018-00325
[24]
Mace, M.L., Gravesen, E., Nordholm, A., et al. (2021) Chronic Kidney Chronic Kidney Disease-Induced Vascular Calcification Impairs Bone Metabolism. Journal of Bone and Mineral Research, 36, 510-522. https://doi.org/10.1002/jbmr.4203
[25]
Isakova, T. (2015) An Introduction to PTH, Phosphate and Vitamin D: Current Issues and Concerns. Seminars in Dialysis, 28, 563. https://doi.org/10.1111/sdi.12445
[26]
Legg, V. (2005) Complications of Chronic Kidney Disease: A Close Look at Renal Osteodystrophy, Nutritional Disturbances, and Inflammation. American Journal of Nursing, 105, 40-49. https://doi.org/10.1097/00000446-200506000-00024
[27]
Alem, A.M., Sherrard, D.J., Gillen, D.L., et al. (2000) Increased Hip Fracture Risk among End-Stage Renal Disease Patients. Kidney International, 58, 396-399. https://doi.org/10.1046/j.1523-1755.2000.00178.x
[28]
Seyedzadeh, A., Tohidi, M.R., Golmohamadi, S., et al. (2022) Prevalence of Renal Osteodystrophy and Its Related Factors among End-Stage Renal Disease Patients Undergoing Hemodialysis: Report from Imam Reza Referral Hospital of Medical University of Kermanshah, Iran. Oman Medical Journal, 37, e335. https://doi.org/10.5001/omj.2021.120
[29]
Elsayed, A., Omar, H., Khater, H., et al. (2020) Bone Densitometry in Children with Chronic Renal Failure. Benha Journal of Applied Sciences, 5, 217-221. https://doi.org/10.21608/bjas.2020.137161
[30]
Bakkaloglu, S.A., Bacchetta, J., Lalayiannis, A.D., et al. (2021) Bone Evaluation in Paediatric Chronic Kidney Disease: Clinical Practice Points from the European Society for Paediatric Nephrology CKD-MBD and Dialysis Working Groups and CKD-MBD Working Group of the ERA-EDTA. Nephrology Dialysis Transplantation, 36, 413-425. https://doi.org/10.1093/ndt/gfaa210
[31]
Huang, Y., Liu, L. and Liu, A. (2018) Dickkopf-1: Current Knowledge and Related Diseases. Life Sciences, 209, 249-254. https://doi.org/10.1016/j.lfs.2018.08.019
[32]
Jo, S., Yoon, S., Lee, S.Y., et al. (2020) DKK1 Induced by 1, 25D3 Is Required to Mineralise Osteoblasts. Cells, 9, Article 236. https://doi.org/10.3390/cells9010236
